Top Markets
Coin of the day
Psyence Group Inc. Psyence Group Inc.

Psyence Group Inc.

PSYG
Pozycja w akcjach #38237
Psyence Group Inc. is a life sciences biotechnology company primarily engaged... Psyence Group Inc. is a life sciences biotechnology company primarily engaged in the commercial cultivation and production of psilocybin mushrooms. This naturally sourced psilocybin is intended for therapeutic applications, addressing a broad spectrum of mental health conditions and other medical ailments. The company is actively formulating pharmaceutical-grade psilocybin treatments designed to mitigate psychological trauma and recognized disorders such as anxiety, depression, post-traumatic stress disorder (PTSD), and the emotional distress linked to grief and bereavement. Furthermore, Psyence Group develops, distributes, and sells over-the-counter functional mushroom nutraceuticals, entirely free of psilocybin, under its GOODMIND brand. Established in 2019, the company maintains its headquarters in Toronto, Canada.
Cena akcji
$0.08765138
Ostatnia synchronizacja: 2025-12-23
Kapitalizacja rynkowa
$1.11M
Zmiana (1 dzień)
0.45%
Zmiana (1 rok)
-28.78%
Kraj
CA
Handel Psyence Group Inc. (PSYG)

Kategoria

Historia ceny akcji dla Psyence Group Inc. (PSYG)
Najwyższa cena zamknięcia: $0.09 dnia 2025-12-01

Najniższa cena zamknięcia: $0.17 dnia 2021-01-01
Historia cen akcji firmy Psyence Group Inc. od 2021 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 10.84%
2025 -20.78%
2024 -39.49%
2023 111.53%
2022 -39.61%
2021 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$1.18K 72.71%
US
$260.38 49.03%
US
$249.16 21.73%
US
$470.54 44.82%
CH
$135.64 63.90%
US